These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2524859)

  • 1. Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.
    Ugedo L; Grenhoff J; Svensson TH
    Psychopharmacology (Berl); 1989; 98(1):45-50. PubMed ID: 2524859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
    Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study.
    Minabe Y; Emori K; Ashby CR
    Synapse; 1996 Jan; 22(1):46-53. PubMed ID: 8822477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons.
    Arborelius L; Chergui K; Murase S; Nomikos GG; Höök BB; Chouvet G; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Apr; 347(4):353-62. PubMed ID: 8510763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ritanserin, a 5-HT2A/2C antagonist, reverses direct dopamine agonist-induced inhibition of midbrain dopamine neurons.
    Shi WX; Nathaniel P; Bunney BS
    J Pharmacol Exp Ther; 1995 Aug; 274(2):735-40. PubMed ID: 7636736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.
    Sorensen SM; Humphreys TM; Taylor VL; Schmidt CJ
    J Pharmacol Exp Ther; 1992 Feb; 260(2):872-8. PubMed ID: 1531362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
    Blackburn TP; Minabe Y; Middlemiss DN; Shirayama Y; Hashimoto K; Ashby CR
    Synapse; 2002 Dec; 46(3):129-39. PubMed ID: 12325040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y; Hashimoto K; Watanabe KI; Ashby CR
    Synapse; 2001 May; 40(2):102-12. PubMed ID: 11252021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study.
    Blackburn TP; Suzuki K; Ashby CR
    Synapse; 2006 Jun; 59(8):502-12. PubMed ID: 16565966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic effects on the firing pattern of midbrain dopamine neurons.
    Grenhoff J; Aston-Jones G; Svensson TH
    Acta Physiol Scand; 1986 Nov; 128(3):351-8. PubMed ID: 3788613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin.
    Lappalainen J; Hietala J; Koulu M; Sjöholm B; Syvälahti E
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):861-72. PubMed ID: 1722342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study.
    Minabe Y; Emori K; Toor A; Stutzmann GE; Ashby CR
    Synapse; 1996 Jan; 22(1):35-45. PubMed ID: 8822476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burst firing of mesencephalic dopamine neurons is inhibited by somatodendritic application of kynurenate.
    Charlety PJ; Grenhoff J; Chergui K; De la Chapelle B; Buda M; Svensson TH; Chouvet G
    Acta Physiol Scand; 1991 May; 142(1):105-12. PubMed ID: 1877358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kynurenate blocks the acute effects of haloperidol on midbrain dopamine neurons recorded in vivo.
    Tung CS; Grenhoff J; Svensson TH
    J Neural Transm Gen Sect; 1991; 84(1-2):53-64. PubMed ID: 2054150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR
    Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with DAU 6215, a new 5-HT3 receptor antagonist, causes a selective decrease in the number of spontaneously active dopaminergic neurons in the rat ventral tegmental area.
    Prisco S; Pessia M; Ceci A; Borsini F; Esposito E
    Eur J Pharmacol; 1992 Apr; 214(1):13-9. PubMed ID: 1582449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons.
    Ashby CR; Jiang LH; Wang RY
    Eur J Pharmacol; 1990 Jan; 175(3):347-50. PubMed ID: 2157603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B; Rothwell LA; Seabrook GR
    Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of serotonin2C receptors blocks the hyperactivation of midbrain dopamine neurons induced by nicotine administration.
    Pierucci M; Di Matteo V; Esposito E
    J Pharmacol Exp Ther; 2004 Apr; 309(1):109-18. PubMed ID: 14722316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intraperitoneal administration of apomorphine and the isomers of 3-(1-propyl-3-piperidinyl)phenol on the firing activity of substantia nigra dopamine neurons: comparison of agonist efficacies and development of acute tolerance.
    Meltzer LT; Christoffersen CL
    Neuropharmacology; 1988 Sep; 27(9):933-42. PubMed ID: 3185867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.